Founded in 2013, Nanjing Heron Pharmaceutical Sci & Tech Co., Ltd. Is an innovation oriented company engaged in the research, development and industrial production of new drugs and first-time generic drugs in China. Active Vitamin D derivatives synthesis and Regulatory Service with Techinical Support are the two critical characteristics of Heron Pharma. In 2016, Heron Pharma successfully landed on the NEEQ Stock market (National Equities Exchange and Quotations, Stock Code: 870070).

Heron Pharma has been elected as the National High-tech Enterprise and was conferred a National Post-Doctoral Workstation. With high-quality of technical services and win-win philosophy, Heron Pharma has established good and stable cooperation relationships with many international well-known organizations, such as Ashland, Gattefosse and Lubrizol.

Heron (Shanghai) Pharma is the pioneer of Heron Group responsible for international business development, including the export of APIs and formulations, technical transfer of technologies as well as import of sophisticated products. Our company grasped the key technologies of photochemistry and microbial transformation to produce the full range of vitamin D analogs. Clinically, they are mainly used for the treatment of osteoporosis, secondary hyperparathyroidism and psoriasis. Besides these drugs, Heron Pharma also provides intermediates and impurities reference substance in compliance with USP, EP and JP monographs.